|Videos|December 14, 2022
Interview with Syngene at CPHI in Frankfurt, Germany
Author(s)Syngene
KEY LEARNING OBJECTIVES
- Syngene is an end-to-end CRO/CDMO which offers standalone as well as integrated services for small molecules and biologics
- We not only have capabilities but also capacity to fulfil commercial manufacturing requirements
- We can be a innovation partner for niche areas as well as small biotech/pharma companies
Related Content
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
4
The Implications of the FDA’s New Finalized Guidance Documents
5